Binding and functional properties of doxazosin in the human prostate adenoma and canine brain
暂无分享,去创建一个
[1] H. Lepor,et al. Nonoperative management of benign prostatic hyperplasia. , 1989, The Journal of urology.
[2] H. Lepor,et al. Contractile properties of human prostate adenomas and the development of infravesical obstruction , 1989, The Prostate.
[3] H. Lepor,et al. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia. , 1988, Urology.
[4] U. Dunzendorfer. Clinical experience: symptomatic management of BPH with terazosin. , 1988, Urology.
[5] H. Lepor,et al. The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain. , 1988, The Journal of urology.
[6] J. Lingeman,et al. Creatinine kinase concentrations and electrocardiographic changes in extracorporeal shock-wave lithotripsy. , 1988, Urology.
[7] H. Lepor,et al. Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat. , 1987, The Journal of urology.
[8] R. Kirby,et al. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. , 1987, British journal of urology.
[9] J. Hieble,et al. In vitro characterization of the alpha-adrenoceptors in human prostate. , 1985, European journal of pharmacology.
[10] H. Lepor,et al. Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia. , 1984, The Journal of urology.
[11] D. Klein,et al. Rat Pineal α1-Adrenoceptors: Identification and Characterization Using [125I]Iodo-2-[β-(4-Hydroxyphenyl)-Ethylaminomethyl]Tetralone , 1984 .
[12] K. Minneman. Binding properties of alpha-1 adrenergic receptors in rat cerebral cortex: similarity to smooth muscle. , 1983, The Journal of pharmacology and experimental therapeutics.
[13] D. Hoyer,et al. [125I]BE 2254, a new high affinity radioligand for α1-adrenoceptors , 1981 .
[14] R. Lefkowitz,et al. Determination of subtype selectivity of alpha-adrenergic antagonists: comparison of selective and nonselective radioligands. , 1981, Molecular pharmacology.
[15] P. Greengrass,et al. Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors , 1979 .
[16] S. Meretyk,et al. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. , 1978, British journal of urology.
[17] P. Braithwaite,et al. Alpha‐adrenergic blockers in prostatism , 1977, The British journal of surgery.
[18] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.